RNA Analytical Quality/Resources
-
Establishing Analytical Methods For mRNA-Based Therapies
6/13/2023
Here, we provide a detailed description of assays for sequence identification and LNP composition in mRNA-LNP products that support the development of safe and effective mRNA therapies.
-
RNA Biotherapeutics — A New Approach To An Old Problem
2/22/2023
Check out a brief history of RNA-based therapy and how Droplet Digital™ PCR supports this field of work.
-
Understanding The Intricacies Of qMSI
9/1/2024
Explore quantitative mass spectrometry imaging (QMSI) and leading spatial bioanalysis and biology services that offers one-on-one support throughout your drug development process.
-
Structural Characterization Of RNA And Detection Of RNA-Ligand Binding
1/13/2025
Delve into the intricacies of riboswitch behavior and ligand interactions and gain valuable insights into gene regulation and potential therapeutic targets.
-
Expression Analysis Of CTLA-4, PD-1, And PD-L1
4/23/2025
Advance personalized immunotherapy in NSCLC by leveraging qPCR-based analysis of CTLA-4, PD-1, and PD-L1 expression to identify predictive biomarkers and guide more effective treatment strategies.
-
Optimizing qPCR For Broad-Range Transcript Detection In Anti-PD-1 Therapy
4/23/2025
Optimize qPCR protocols for greater sensitivity and reproducibility to accurately measure immune-related gene expression and better identify patients who will benefit from anti-PD-1 immunotherapy.
-
Future-Proofing mRNA Drug Manufacturing: The Value of Continuous Improvement
4/30/2024
With so many uncertainties permeating the mRNA market, this largely preclinical industry is still seeking answers on how to reach successful therapeutic development. Identifying optimizations, both sequence-dependent and otherwise, to enhance the manufacturing process is crucial for advancing mRNA product development, which holds vast potential to address a wide range of indications.
-
Gene Therapy And Oligonucleotide Compendium
1/25/2022
Technical summaries and detailed protocols for purity testing, sizing, sequencing and expression analysis of oligonucleotide-based active agents as well as protein and lipid-based delivery systems.
-
How A Drug's Molecule Type Affects Several Bioanalysis Parameters
9/1/2024
Discover why bioanalytics are crucial to selecting promising drug candidates during development and to characterizing the pharmacokinetic and pharmacodynamic profile of the drug in early clinical trials.
-
Targeted LC-MS/MS Detection Of Lipid Impurities In Lipid Nanoparticles
12/9/2024
Learn about an HPLC-MS/MS method for detecting lipid impurities in lipid nanoparticles (LNPs) and why it is critical for quality control of LNP-based drug delivery systems.